Search results :

Oxybutynin

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: G04BD04

Side effects

Options: Show MedDRA Preferred Terms,   display all 43 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Gastrointestinal disorder postmarketing, 71.4% x x x x x x x x x
Constipation common, 0% - 15.1% 0% x x x x x
Dry mouth common, 0.7% - 72.4% 1.7% - 8.3% x x x x x x x x x x x x x x x x x x x x
Headache common, 1.5% - 8% x x x x x x x x x x x x x x x
Infection 6.5% x x x x x x x x
Diarrhoea common, 2.3% - 7.9% 2.3% x x x x x x x x x x x x x x x
Nervousness 1.5% - 6.5% x x x x x x x x
Urinary tract infection 5.2% - 6.94% 4.25% x x x x x x x x x x x x
Infestation NOS 6.5% x x x x x x x x
Application site erythema common, 1.7% - 10% 0.99% - 2.3% x x x x x
Somnolence postmarketing — 5.6% - 14.1% x x x x x x x x x x x x x
Urinary hesitation 1.9% - 8.5% x x x x x x x
Dyspepsia uncommon, 4.5% - 6% x x x x x x x x x x
Nausea common, 1.9% - 11.6% x x x x x x x x x x x x x x x x
Application site pruritus 2.1% - 16.8% x x x x x
Dizziness postmarketing — 1.5% - 16.6% 1% x x x x x x x x x x x x x x x x x
Application site reaction common x x x x x
Vision blurred common, 2.3% - 9.6% x x x x x x x x x x x x x
Insomnia 2.8% - 5.5% x x x x x x x x x x x x x
Nasal dryness 1.7% - 4.5% x x x x x x x x x x
Keratoconjunctivitis sicca 2.5% - 4.2% x x x x
Application site rash common, 0.9% - 4% 0.495% - 0.9% x x x x x x
Oedema peripheral 2.5% - 4% x x x x x x x x
Application site vesicles 0% - 4% 0% x x x
Fatigue 2.06% - 3.1% 1% x x x x x x x x x x x
Urinary retention uncommon, 1.2% - 6% x x x x x x x x x x
Abdominal pain upper 3% x x x x
Residual urine volume 2.3% - 3.5% x
Dry eye 2.5% - 3.1% x x x x x x x
Cough 1.9% - 3% x x x x x x x x x
Nasopharyngitis 1.5% - 2.83% 2.25% x x x x x x x x x
Upper respiratory tract infection uncommon, 2.2% - 5.4% 5% x x x x x x x x x x
Dry skin 1.8% - 3% x x x x x x x x x x x
Macule 0% - 3% 0% x x x
Abnormal vision 0% - 3% 0% x x x
Loose stools 1.4% - 3% x x x x x x
Asthenia 1.7% - 2.5% x x x x x x x x x x x x x
Dry throat 1.6% - 2.5% x x x x x x x x
Viral diarrhoea 2.06% 1.75% x
Abdominal pain common, 1.5% - 2.5% x x x x x x x x x x x x x
Back pain uncommon, 2% - 2.4% x x x x x x x x x x x
Dysuria uncommon, 0% - 3% 0% x x x x x x x x
Nasal congestion 2% x x x x
Sinus headache 2% x x x x
Sinus congestion 2% x x x x
Flatulence 1.2% - 2.5% x x x x x x x x x x x x
Arthralgia 1.5% - 2% x x x x x x x
Confusional state 1% - 2.5% x x x x x x x x x x
Depression 1.7%
Sinusitis 1.7% x x x x
Pharyngolaryngeal pain 1.5% - 1.9% x x x x x x x
Oropharyngeal pain 1.5% - 1.9% x
Bronchitis 1.2% - 2% x x x x x x x x
Dysphagia 1.5% x x x x x x x x
Dysgeusia 1.1% - 1.6% x x x x x x x x x
Palpitations uncommon, 1.5% - 4.5% x x x x x x x x x x x x x
Blood glucose increased 1.5% x x x x
Vomiting 1.2% - 1.5% x x x x x x x x x x
Chest pain 1.3% x x x x
Hypertension 1.3% x x x x x
Pruritus very common, 1.3% - 1.5% x x x x x x x x x x x
Blood pressure increased 1% - 1.5% x x x x x x
Pain in extremity 1% - 1.3% x x x x x x x
Sinus arrhythmia 1% x x x x
Asthma 1% x x x x
Tongue coated 1% x x x x
Cystitis 1% x x x x x x x x
Oedema 1% x x x x x
Eructation 1% x x x x
Flank pain 1% x x x x
Gastrooesophageal reflux disease 0.5% - 1.6% x x x x x x
Hoarseness 1% x x x
Hypotension 1% x x x x
Fungal infection uncommon, 1% x x x x x
Pain 1% x x x x x x x x
Thirst 1% x x x x x x
Pollakiuria 1%
Eye irritation 1% x x x x
Fluid retention 1% x x x x x x
Rhinitis uncommon x x x x
Abdominal discomfort uncommon x x
Inflicted injury uncommon x
Hot flush uncommon x x x
Airway obstruction NOS postmarketing x x x x x
Anaphylactic shock postmarketing x x x x x
Angioedema postmarketing x x x x x x
Arrhythmia postmarketing x x x x x
Mental disorder postmarketing, 5.5% x x x x x x x x
Breast disorder postmarketing x x x
Rash postmarketing x x x x x x x x x x x x x x
Eye disorder postmarketing, 9.6% x x x x x x
Flushing postmarketing, 1% x x x x x x x x x x x x
Glaucoma postmarketing x x
Hallucination postmarketing x x x x x x x x x x x x
Cardiac disorder postmarketing x x x x x x x x x
Hypersensitivity postmarketing x x x x x x
Mydriasis postmarketing x x x x x x x x x x x x x
Nervous system disorder postmarketing, 16.6% x x x x x x x x
Psychotic disorder postmarketing x x x x x x x
Convulsion postmarketing x x x x x x x x x
Tachycardia postmarketing x x x x x x x x x x x x x
Urinary tract disorder postmarketing, 8.5% x x x x x x x x x
Urticaria postmarketing, uncommon x x x x x x x
Angiopathy postmarketing x x x x x x x x x
Agitation postmarketing x x x x x x x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x x
Memory impairment postmarketing x x x x x x
Cycloplegia postmarketing x x x x x x x x x x x x x
Erectile dysfunction postmarketing x x x x x x x x x x x x x
Face oedema postmarketing x x x x x
Sweating decreased postmarketing x x x x x x x x
Amblyopia x x x
Amnesia
Anorexia x x x x
Anxiety x
Arthritis x
Cognitive disorder x
Colitis
Conjunctivitis x
Connective tissue disorder x x x x x x x x
Libido decreased
Depersonalisation
Dermatitis x
Drowsiness x x x x
Epistaxis x
Oesophagitis
Angle closure glaucoma x
Glossitis
Hair disorder
Breath odour
Heat stroke x
Haematuria
Hiccups
Hypoaesthesia
Influenza x
Iritis
Arthropathy
Lung disorder
Mediastinal disorder x x x x x x x x
Melaena
Hypertonia
Nail disorder
Nightmare x
Nocturia
Paraesthesia
Pharyngitis x
Salivary hypersecretion
Stomatitis
Syncope x
Tenosynovitis
Tinnitus
Tongue disorder
Erythema x
Urethritis
Vasodilation x x
Micturition urgency
Mood swings x
Depressive symptom x
Mouth ulceration
Migraine
Creatinine increased
Tongue discolouration
Generalised oedema
Accidental injury x
Liver function test abnormal
Lack of drug effect
Eye pain
Urethral pain
Circumoral paresthesia
Vesiculobullous rash
Skin discolouration
Malnutrition x x x x x x
Malaise
Urination impaired x
Increased appetite
Tension x
Thinking abnormal
Chest discomfort x x
Lacrimation decreased x x x
Frequent bowel movements x x
Taste metallic x
Enlargement abdomen
Akathisia
Hyperkinesia
Cough increased
Cutaneous hypersensitivity x
Ear and labyrinth disorders x
Sleep disorder
Bloated feeling x
Application site burn x x
Detrusor instability x
Increased upper airway secretion
Paranoia x
Dysphonia x x
Ageusia

Indications

Information about indications was extracted from the indications and usage sections of the labels.

OXYBUTYNIN

Side effects:10
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:14
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:16
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:17
Source:FDA Structured Product Label

oxybutynin

Side effects:18
Source:FDA Structured Product Label

OXYBUTYNIN / OXYTROL

Side effects:21
Source:FDA

OXYBUTYNIN / OXYTROL

Side effects:22
Source:FDA

OXYBUTYNIN CHLORIDE / PHL-OXYBUTYNIN

Side effects:28
Source:Health Canada

/ Ditropan XL Tablets

Side effects:32
Source:FDA

oxybutynin / oxybutynin

Side effects:35
Source:EMA

OXYBUTYNIN CHLORIDE / DITROPAN XL

Side effects:40
Source:FDA

Each tablet contains oxybutynin hydrochloride / DITROPAN

Side effects:41
Source:medicines.org.au

OXYBUTYNIN

Side effects:60
Source:FDA Structured Product Label

oxybutynin

Side effects:65
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:67
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:73
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:79
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:80
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:89
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:90
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label